JCEM case reports最新文献

筛选
英文 中文
Impaired 11β-HSD1 Activity in a Male Patient With Cushing Disease Resulting in Lack of the Full Cushingoid Phenotype. 一名男性库欣病患者的 11β-HSD1 活性受损,导致缺乏完整的库欣样表型。
JCEM case reports Pub Date : 2024-09-05 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae158
Robert J Weber, Christopher Kawaja, Robert Wallerstein, Sandeep M Kunwar, Chienying Liu
{"title":"Impaired 11β-HSD1 Activity in a Male Patient With Cushing Disease Resulting in Lack of the Full Cushingoid Phenotype.","authors":"Robert J Weber, Christopher Kawaja, Robert Wallerstein, Sandeep M Kunwar, Chienying Liu","doi":"10.1210/jcemcr/luae158","DOIUrl":"10.1210/jcemcr/luae158","url":null,"abstract":"<p><p>We present a patient who had surgically confirmed CD but without the full cushingoid phenotype despite markedly elevated cortisol. Nonpathologic causes of elevated ACTH and cortisol were eliminated as were pathogenic variants in the glucocorticoid receptor gene. Further studies of urine metabolites, cortisol half-life, and the ratios of cortisone to cortisol conversion revealed impaired 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity. There have only been 2 prior reports of impaired 11β-HSD1 resulting in lack of classic cushingoid features in the past 2 decades. Our patient's presentation and previous reports demonstrate the key role of 11β-HSD1 in modulating intracellular cortisol concentration, therefore shielding the peripheral tissues from the effects of excess cortisol. When patients present with markedly elevated cortisol but without classic cushingoid features, impaired 11β-HSD1 should be considered in the differential diagnosis.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae158"},"PeriodicalIF":0.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When the Expected Becomes Unexpected: An Acute Presentation of Hypothyroidism. 当意料之中变成意料之外:甲状腺功能减退症的急性表现。
JCEM case reports Pub Date : 2024-09-05 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae154
Andrea Martinez Sanchez, Claudia Vega Castellvi, Joshua Tarkoff, Christie De La Vega
{"title":"When the Expected Becomes Unexpected: An Acute Presentation of Hypothyroidism.","authors":"Andrea Martinez Sanchez, Claudia Vega Castellvi, Joshua Tarkoff, Christie De La Vega","doi":"10.1210/jcemcr/luae154","DOIUrl":"10.1210/jcemcr/luae154","url":null,"abstract":"<p><p>Myxedema coma is an uncommon and life-threatening manifestation of severe hypothyroidism. Its occurrence in the pediatric population is exceptionally rare and can result from long-standing untreated hypothyroidism or nonadherence to treatment. Identifying this condition can be challenging because it requires a high level of clinical suspicion along with thyroid function testing. We present a 17-year-old female with a history of anxiety who had widespread nonspecific symptoms, including persistent bradycardia, which were found to be caused by hypothyroidism. Our goal is to raise awareness of the varied clinical manifestations of pediatric myxedema to promote early recognition and prompt medical interventions that can lead to better outcomes.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae154"},"PeriodicalIF":0.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes. 一名无糖尿病患者因塞马鲁肽引发的酮症酸中毒
JCEM case reports Pub Date : 2024-08-30 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae156
Nikhil Sood, Ojas Bansal, Rohini Garg, Abhinav Hoskote
{"title":"Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes.","authors":"Nikhil Sood, Ojas Bansal, Rohini Garg, Abhinav Hoskote","doi":"10.1210/jcemcr/luae156","DOIUrl":"10.1210/jcemcr/luae156","url":null,"abstract":"<p><p>Euglycemic ketoacidosis is a medical emergency characterized by euglycemia, metabolic acidosis, and ketonemia. It is a well-recognized adverse event in patients with diabetes taking sodium-glucose cotransporter-2 inhibitors. However, little has been reported about euglycemic ketoacidosis using glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide. We present a case of euglycemic ketoacidosis in a young female without diabetes who was taking semaglutide for weight loss for the last 7 months. She was treated with bicarbonate-containing dextrose infusion, which improved the ketoacidosis rapidly. The incidence of euglycemic ketoacidosis will likely increase with the increasing use of GLP-1 inhibitors, and recognizing the signs and symptoms of this life-threatening condition is essential to treat it effectively. Our literature search identified 1 reported case of euglycemic ketoacidosis in a patient without diabetes associated with tirzepatide but none with semaglutide.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae156"},"PeriodicalIF":0.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Cases of Improved Bone Mineral Density Following Treatment of Hypophosphatemic Osteomalacia Due to FGF23 Excess. 两例因 FGF23 过量而导致的低磷血症骨软化症患者在接受治疗后骨密度得到改善
JCEM case reports Pub Date : 2024-08-27 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae073
Lara McHan, Marilyn Augustine
{"title":"Two Cases of Improved Bone Mineral Density Following Treatment of Hypophosphatemic Osteomalacia Due to FGF23 Excess.","authors":"Lara McHan, Marilyn Augustine","doi":"10.1210/jcemcr/luae073","DOIUrl":"https://doi.org/10.1210/jcemcr/luae073","url":null,"abstract":"<p><p>Excess fibroblast growth factor-23 (FGF23) causes renal phosphorous wasting and impaired activation of vitamin D leading to osteomalacia. Tumor-induced osteomalacia (TIO) is a rare cause of FGF23-mediated hypophosphatemia. We present 2 patients with FGF23-mediated hypophosphatemia who had low bone mineral density (BMD) at diagnosis and remarkable improvements in BMD with treatment. Patient 1 is a 43-year-old man who had years of progressive pain, difficulty ambulating, and multiple fractures. Patient 2 is a 48-year-old nonverbal man with autism and intellectual disability who had months of progressively declining mobility, presumed pain, and multiple fractures. Workup in both cases revealed hypophosphatemia, evidence of renal phosphorous wasting, and elevated FGF23. Patient 1 was diagnosed with TIO when imaging identified a subcutaneous left flank mass and excision resulted in rapid symptom improvement; he experienced a 96% increase in lumbar spine (LS) BMD after surgery. Patient 2 has had multiple scans over several years, but no FGF23-secreting tumor has been identified. He has been maintained on medical treatment with phosphorous and calcitriol with improvement in functioning and 48% increase in LS BMD. Both patients had improvements in BMD with treatment, with more pronounced improvement in the patient with TIO managed surgically.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae073"},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11408272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Growth Hormone Deficiency in an Adolescent With Pseudohypoparathyroidism Type 1B. 假性甲状旁腺功能减退症1B型青少年生长激素缺乏症
JCEM case reports Pub Date : 2024-08-27 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae152
Sabitha Sasidharan Pillai, Monica Reyes, Harald Jüppner, Lisa Swartz Topor
{"title":"Growth Hormone Deficiency in an Adolescent With Pseudohypoparathyroidism Type 1B.","authors":"Sabitha Sasidharan Pillai, Monica Reyes, Harald Jüppner, Lisa Swartz Topor","doi":"10.1210/jcemcr/luae152","DOIUrl":"10.1210/jcemcr/luae152","url":null,"abstract":"<p><p>We report growth hormone (GH) deficiency due to presumed GH releasing hormone (GHRH) resistance in an adolescent with pseudohypoparathyroidism type 1B (PHP1B) due to paternal uniparental disomy of chromosome 20 (patUPD20). A male patient aged 11 years 10 months with obesity and mild developmental delay was found to have hypocalcemia, hyperphosphatemia, and an elevated parathyroid hormone level. History included muscle cramps and leg pain with activity. Examination showed round facies, short stature, and obesity. He was in puberty and bone age was advanced by > 2 years. Detailed genetic workup, including nucleotide sequence analysis of <i>GNAS</i> exons 1-13 and <i>STX16</i>, methylation-sensitive multiplex ligation-dependent probe amplification and analysis of several microsatellite markers for chromosome 20, established the diagnosis of PHP1B due to patUPD20. Muscle cramps and hypocalcemia resolved with calcium carbonate, ergocalciferol, and calcitriol treatment. He was short with linear growth deceleration at around age 13 years. Peak GH concentration was insufficient following stimulation testing. Growth velocity improved with human GH treatment. Although rare, resistance to GHRH can occur in PHP1B and patients with this disorder should be evaluated for GH insufficiency if they present with short stature and reduced growth velocity. Treatment with recombinant human GH may improve growth velocity in such patients.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae152"},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Tamponade as a Harbinger of Hypothyroidism. 心脏填塞是甲状腺功能减退症的先兆
JCEM case reports Pub Date : 2024-08-23 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae150
Fateen Ata, Fatima Al-Hattab, Ammara Bint I Bilal, Ezeddin Alataresh, Haval Surchi
{"title":"Cardiac Tamponade as a Harbinger of Hypothyroidism.","authors":"Fateen Ata, Fatima Al-Hattab, Ammara Bint I Bilal, Ezeddin Alataresh, Haval Surchi","doi":"10.1210/jcemcr/luae150","DOIUrl":"10.1210/jcemcr/luae150","url":null,"abstract":"<p><p>Cardiac tamponade is a rare complication of hypothyroidism. In rarer cases, hypothyroidism may initially present with tamponade. Cardiac tamponade is an emergency condition that usually requires urgent intervention. However, guidelines for tamponade secondary to hypothyroidism are not optimal, and cases have been managed variably (ranging from levothyroxine alone to pericardiocentesis followed by thyroid hormone replacement) with diverse outcomes. Here, we report a case of a 42-year-old male with no medical history who presented with exertional dyspnea, lower leg swelling, facial puffiness, constipation, and weight gain. He had low blood pressure (80/60 mm Hg), normal heart rate with sinus rhythm, normal oxygen saturation, and was afebrile. Apart from a mildly raised creatinine, his test results were normal. An echocardiogram revealed features of tamponade. Further laboratory tests showed severe hypothyroidism. Following the initiation of levothyroxine, he demonstrated significant improvement. Coronary angiography revealed 95% stenosis in the mid-left anterior descending artery, treated with stenting. Serial echocardiograms showed regression of the pericardial effusion, stabilizing his condition without the need for invasive pericardiocentesis. This case highlights the importance of prompt diagnosis and management of hypothyroidism-related tamponade to prevent severe cardiac compromise. Hence, it may be necessary to consider hypothyroidism in the differential for patients with unexplained cardiac tamponade.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae150"},"PeriodicalIF":0.0,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymphoid Structure Presenting as a Hypermetabolic Adrenal Incidentaloma. 淋巴结构表现为高代谢性肾上腺偶发瘤
JCEM case reports Pub Date : 2024-08-21 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae149
Xavier Gilis, Thomas Servais, Guillaume Pierman, Marie-Cécile Nollevaux, Etienne Delgrange
{"title":"Lymphoid Structure Presenting as a Hypermetabolic Adrenal Incidentaloma.","authors":"Xavier Gilis, Thomas Servais, Guillaume Pierman, Marie-Cécile Nollevaux, Etienne Delgrange","doi":"10.1210/jcemcr/luae149","DOIUrl":"10.1210/jcemcr/luae149","url":null,"abstract":"<p><p>Adrenal incidentalomas are a frequent cause for consultation in endocrinology. Current guidelines provide an algorithm for their evaluation to determinate the risk of hormonally active or malignant condition. We report a unique case of benign adrenal incidentaloma in a 53-year-old woman with multiple malignancy criteria on contrast-free computed tomography and [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography-computed tomography, leading to a left adrenalectomy. Histopathologic analysis showed a 15-mm intra-adrenal lymphoid organ localized in the medulla, without any cellular atypia and organized with a capsule and multiple germinal centers. The surrounding adrenal tissue was unremarkable, and the patient did not develop any inflammatory, infectious, or neoplastic disease during the 2 following years. This is the first described case of a well-organized intra-adrenal ectopic lymphoid organ in the absence of any evident stimulus.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae149"},"PeriodicalIF":0.0,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142020125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Starvation Ketoacidosis in Pregnancy: An Unusual Presentation and Brief Literature Review. 妊娠期饥饿性酮症酸中毒:妊娠期饥饿性酮症酸中毒:不寻常的表现和简要的文献综述。
JCEM case reports Pub Date : 2024-08-16 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae145
Lisa Abraham, Xinyuan Ning, Hilary B Whitlatch
{"title":"Starvation Ketoacidosis in Pregnancy: An Unusual Presentation and Brief Literature Review.","authors":"Lisa Abraham, Xinyuan Ning, Hilary B Whitlatch","doi":"10.1210/jcemcr/luae145","DOIUrl":"10.1210/jcemcr/luae145","url":null,"abstract":"<p><p>Starvation ketoacidosis in pregnant patients is a rare but life-threatening condition that requires prompt diagnosis and timely treatment. A 35-year-old pregnant woman at 33 weeks' gestation was admitted for abdominal pain with poor oral intake. She was diagnosed with perforated appendicitis and underwent emergent laparotomy. During the procedure and afterwards, she was found to have an anion gap metabolic acidosis. She was treated with a dextrose infusion with a fixed-rate insulin with correction of metabolic parameters. Women in late pregnancy are at increased risk for ketosis from increased relative insulin resistance and enhanced lipolysis. There is no consensus on optimal management of starvation ketoacidosis of pregnancy; however, carbohydrate administration is a cornerstone of treatment. We chose simultaneous administration of carbohydrates with insulin to overcome any inherent insulin resistance and to suppress lipolysis with rapid resolution of the patient's metabolic derangements.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae145"},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in SDHD. 甲状旁腺瘤:副神经节瘤综合征的一种罕见表现与 SDHD 的致病变异有关。
JCEM case reports Pub Date : 2024-08-16 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae135
Valentina D Tarasova, Kelara Samuel, Caitlin McMullen, Sergiy Kushchayev, Juan C Hernandez Prera, Colleen Veloski
{"title":"Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in <i>SDHD</i>.","authors":"Valentina D Tarasova, Kelara Samuel, Caitlin McMullen, Sergiy Kushchayev, Juan C Hernandez Prera, Colleen Veloski","doi":"10.1210/jcemcr/luae135","DOIUrl":"10.1210/jcemcr/luae135","url":null,"abstract":"<p><p>Evaluation of an incidentally discovered indeterminate thyroid nodule (TN) in a previously healthy 59-year female led to diagnosis of thyroid paraganglioma (TPGL) and subsequently hereditary succinate dehydrogenase complex subunit D (<i>SDHD)</i>-related multifocal head and neck paragangliomas (PGLs). An ultrasound-guided fine needle aspiration (FNA) biopsy of the 1.7-cm TN was nondiagnostic and core biopsy was suspicious for papillary thyroid carcinoma. Pathology slides reviewed at tertiary center showed neuroendocrine neoplasm consistent with PGL. Her 24-hour urinary catecholamines and metanephrines were normal. Given the diagnosis of TPGL, genetic testing was recommended, which identified a pathogenic variant in <i>SDHD</i> (c.242C > T(p.P81L). Gallium-68-DOTATATE PET/CT revealed multifocal areas of increased somatostatin receptor expression from the skull base to thoracic inlet. Magnetic resonance imaging of the brain/neck showed multiple PGLs (right jugular, carotid, thyroid, left vagal, left level II, and superior mediastinal), all measured up to 1.7 cm. The right jugular PGL was treated with external beam radiation therapy of 3000 cGy. All PGLs remained stable and asymptomatic at 22-month follow-up imaging. TPGL should be considered in the differential diagnosis of a hypervascular TN in patients with <i>SDH</i>x-related pheochromocytoma-PGL syndromes and when such lesions with indeterminate cytology are encountered in patients with no known history of <i>SDHx</i>-mutation or syndrome.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae135"},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypercalcemia in Pregnancy Caused by a Uterine Myoma. 子宫肌瘤导致的妊娠高钙血症
JCEM case reports Pub Date : 2024-08-14 eCollection Date: 2024-09-01 DOI: 10.1210/jcemcr/luae126
Stephanie van der Leij, Doenja Hertog
{"title":"Hypercalcemia in Pregnancy Caused by a Uterine Myoma.","authors":"Stephanie van der Leij, Doenja Hertog","doi":"10.1210/jcemcr/luae126","DOIUrl":"10.1210/jcemcr/luae126","url":null,"abstract":"<p><p>We present a case of a PTH-related peptide (PTH-rp) producing uterine myoma, leading to hypercalcemia in pregnancy. Our patient presented with dehydration, hypotension, delirium, and malnutrition. Due to a serum calcium level of 17.9 mg/dL (4.48 mmol/L) (reference range 8.8-11.2 mg/dL; 2.20-2.80 mmol/L), prompt treatment with hydration and calcitonin was initiated. The patient went into labor before we could consider other treatment options. Although uncommon in pregnancy, it is of great importance to identify hypercalcemia since it is related to a high risk of maternal and neonatal morbidity and mortality. Because bisphosphonates are contraindicated in pregnancy, hydration and calcitonin are the cornerstones of treatment for PTH-rp-induced hypercalcemia.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 9","pages":"luae126"},"PeriodicalIF":0.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11322734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141986720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信